Form 13-F position report

QUALIGEN THERAPEUTICS INC

Reported by Bank of America Corporation

AIXC CUSIP 74754R301 Manager CIK 0000070858

Reported 22 shares, unchanged from the prior quarter.

Reported value -13.0%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q1 2025
Shares 22 Quarter-end amount reported
Reported value $80 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-12-31 92
2025-03-31 80
2025-06-30 20
2025-09-30 80
2025-12-31 33
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for QUALIGEN THERAPEUTICS INC held by Bank of America Corporation.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -14 (-100.0%) 0 $0 2026-05-18
Q4 2025 Unchanged 14 0 (0.0%) < 0.01% $33 2026-02-17
Q3 2025 Added 14 +8 (133.3%) < 0.01% $80 2025-11-14
Q2 2025 Reduced 6 -16 (-72.7%) < 0.01% $20 2025-08-14
Q1 2025 Unchanged 22 0 (0.0%) < 0.01% $80 2025-05-15
Q4 2024 New 22 +22 (0.0%) < 0.01% $92 2025-02-14

Who else reported the position

16 managers reported QUALIGEN THERAPEUTICS INC for Q1 2025.

Managers reporting QUALIGEN THERAPEUTICS INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Coastal Bridge Advisors LLC New 27,473 +27,473 < 0.01% $100,002 1 qtr
FNY Investment Advisers LLC New 7,548 +7,548 0.02% $27,000 1 qtr
BlackRock Inc Unchanged 511 0 < 0.01% $1,860 2 qtrs
Tower Research Capital LLC TRC Reduced 374 -1,058 < 0.01% $1,361 2 qtrs
HighMark Wealth Management LLC Unchanged 160 0 < 0.01% $582 2 qtrs
Bank of America Corporation This report Unchanged 22 0 < 0.01% $80 2 qtrs
GROUP ONE TRADING L P Unchanged 8 0 < 0.01% $29 2 qtrs
US BANCORP DE Unchanged 7 0 < 0.01% $25 2 qtrs
UMA Financial Services Inc Unchanged 2 0 < 0.01% $8 2 qtrs
DANSKE BANK A S Unchanged 1 0 < 0.01% $4 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 15, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
6
None
16

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.